2020 Q2 Form 10-Q Financial Statement
#000156459020029953 Filed on June 19, 2020
Income Statement
| Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
|---|---|---|---|
| Revenue | $1.812M | $2.360M | $2.218M |
| YoY Change | -21.93% | 6.4% | -15.76% |
| Cost Of Revenue | $719.0K | $857.0K | $841.0K |
| YoY Change | -16.1% | 1.9% | 1.94% |
| Gross Profit | $1.093M | $1.503M | $1.377M |
| YoY Change | -25.34% | 9.15% | -23.84% |
| Gross Profit Margin | 60.32% | 63.69% | 62.08% |
| Selling, General & Admin | $1.725M | $1.655M | $2.178M |
| YoY Change | -19.28% | -24.01% | -0.18% |
| % of Gross Profit | 157.82% | 110.11% | 158.17% |
| Research & Development | $200.0K | $303.0K | $653.0K |
| YoY Change | -25.37% | -53.6% | -19.48% |
| % of Gross Profit | 18.3% | 20.16% | 47.42% |
| Depreciation & Amortization | $65.00K | $63.00K | $72.00K |
| YoY Change | -1.52% | -12.5% | 5.88% |
| % of Gross Profit | 5.95% | 4.19% | 5.23% |
| Operating Expenses | $1.925M | $303.0K | $653.0K |
| YoY Change | -19.96% | -53.6% | -78.18% |
| Operating Profit | -$832.0K | -$455.0K | -$1.489M |
| YoY Change | -11.58% | -69.44% | 25.65% |
| Interest Expense | -$254.0K | $28.00K | $14.00K |
| YoY Change | -1370.0% | 100.0% | -96.0% |
| % of Operating Profit | |||
| Other Income/Expense, Net | $82.00K | $583.0K | |
| YoY Change | -85.93% | 64.23% | |
| Pretax Income | -$1.086M | -$373.0K | -$906.0K |
| YoY Change | 67.59% | -58.83% | 9.16% |
| Income Tax | $0.00 | ||
| % Of Pretax Income | |||
| Net Earnings | -$1.086M | -$373.0K | -$906.0K |
| YoY Change | 67.59% | -58.83% | 9.16% |
| Net Earnings / Revenue | -59.93% | -15.81% | -40.85% |
| Basic Earnings Per Share | |||
| Diluted Earnings Per Share | -$144.1K | -$49.48K | -$122.4K |
| COMMON SHARES | |||
| Basic Shares Outstanding | 7.539M | ||
| Diluted Shares Outstanding |
Balance Sheet
| Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $1.315M | $708.0K | $620.0K |
| YoY Change | 119.17% | 14.19% | 37.78% |
| Cash & Equivalents | $708.0K | $615.0K | |
| Short-Term Investments | |||
| Other Short-Term Assets | $379.0K | $434.0K | $480.0K |
| YoY Change | -13.86% | -9.58% | -25.0% |
| Inventory | $1.010M | $1.100M | $1.460M |
| Prepaid Expenses | |||
| Receivables | $694.0K | $1.138M | $960.0K |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $3.398M | $3.380M | $3.510M |
| YoY Change | 2.1% | -3.7% | 2.93% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $1.613M | $630.0K | $1.590M |
| YoY Change | 131.42% | -60.38% | 367.65% |
| Goodwill | |||
| YoY Change | |||
| Intangibles | $1.351M | ||
| YoY Change | |||
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $427.0K | $448.0K | $870.0K |
| YoY Change | -51.48% | -48.51% | 10.13% |
| Total Long-Term Assets | $3.385M | $3.496M | $5.150M |
| YoY Change | -35.07% | -32.12% | 26.85% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $3.398M | $3.380M | $3.510M |
| Total Long-Term Assets | $3.385M | $3.496M | $5.150M |
| Total Assets | $6.783M | $6.876M | $8.660M |
| YoY Change | -20.58% | -20.6% | 15.93% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $579.0K | $534.0K | $810.0K |
| YoY Change | -20.79% | -34.07% | -49.69% |
| Accrued Expenses | $830.0K | $718.0K | $1.250M |
| YoY Change | 51.46% | -42.56% | 45.35% |
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $2.422M | $2.395M | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | |||
| YoY Change | |||
| Total Short-Term Liabilities | $4.081M | $4.205M | $4.470M |
| YoY Change | -8.46% | -5.93% | -23.33% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $654.0K | $0.00 | $0.00 |
| YoY Change | |||
| Other Long-Term Liabilities | $1.353M | $1.214M | $1.010M |
| YoY Change | 39.48% | 20.2% | |
| Total Long-Term Liabilities | $2.007M | $1.214M | $1.010M |
| YoY Change | 106.91% | 20.2% | |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $4.081M | $4.205M | $4.470M |
| Total Long-Term Liabilities | $2.007M | $1.214M | $1.010M |
| Total Liabilities | $6.088M | $5.419M | $5.477M |
| YoY Change | 12.08% | -1.06% | -6.05% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | -$107.6M | ||
| YoY Change | 2.09% | ||
| Common Stock | $8.000K | ||
| YoY Change | |||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | |||
| YoY Change | |||
| Treasury Stock Shares | |||
| Shareholders Equity | -$3.605M | -$2.843M | -$1.114M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $6.783M | $6.876M | $8.663M |
| YoY Change | -20.57% | -20.63% | 16.0% |
Cashflow Statement
| Concept | 2020 Q2 | 2020 Q1 | 2019 Q1 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | -$1.086M | -$373.0K | -$906.0K |
| YoY Change | 67.59% | -58.83% | 9.16% |
| Depreciation, Depletion And Amortization | $65.00K | $63.00K | $72.00K |
| YoY Change | -1.52% | -12.5% | 5.88% |
| Cash From Operating Activities | -$18.00K | $265.0K | -$341.0K |
| YoY Change | -97.22% | -177.71% | 610.42% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$29.00K | $3.000K | $58.00K |
| YoY Change | -83.14% | -94.83% | 1.75% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | |||
| YoY Change | |||
| Cash From Investing Activities | -$29.00K | -$41.00K | -$119.0K |
| YoY Change | -83.14% | -65.55% | -40.8% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 654.0K | -53.00K | |
| YoY Change | -18.25% | -113.52% | |
| NET CHANGE | |||
| Cash From Operating Activities | -18.00K | 265.0K | -341.0K |
| Cash From Investing Activities | -29.00K | -41.00K | -119.0K |
| Cash From Financing Activities | 654.0K | -53.00K | |
| Net Change In Cash | 607.0K | 224.0K | -460.0K |
| YoY Change | -3135.0% | -148.7% | -421.68% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | -$18.00K | $265.0K | -$341.0K |
| Capital Expenditures | -$29.00K | $3.000K | $58.00K |
| Free Cash Flow | $11.00K | $262.0K | -$399.0K |
| YoY Change | -102.31% | -165.66% | 280.0% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| CY2019Q4 | us-gaap |
Notes Payable Related Parties Noncurrent
NotesPayableRelatedPartiesNoncurrent
|
2370000 | |
| CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1913000 | |
| CY2020Q1 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
1067000 | |
| CY2019Q4 | us-gaap |
Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
|
717000 | |
| CY2020Q1 | isco |
Deposits And Other Assets
DepositsAndOtherAssets
|
73000 | |
| CY2019Q4 | isco |
Deposits And Other Assets
DepositsAndOtherAssets
|
90000 | |
| CY2020Q1 | us-gaap |
Assets
Assets
|
6876000 | |
| CY2019Q4 | us-gaap |
Assets
Assets
|
6620000 | |
| CY2020Q1 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
534000 | |
| CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
654000 | |
| CY2020Q1 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
718000 | |
| CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
642000 | |
| CY2020Q1 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
308000 | |
| CY2020Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NONE | |
| CY2020Q1 | dei |
Entity File Number
EntityFileNumber
|
0-51891 | |
| CY2020Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4494098 | |
| CY2020Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
5950 Priestly Drive | |
| CY2020Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Carlsbad | |
| CY2020Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2815000 | |
| CY2020Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
CA | |
| CY2020Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
92008 | |
| CY2020Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-455000 | |
| CY2020Q1 | dei |
City Area Code
CityAreaCode
|
760 | |
| CY2020Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
940-6383 | |
| CY2020Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
7539089 | |
| CY2020Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | |
| CY2020Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
| CY2020Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
| CY2020Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
| CY2019Q4 | us-gaap |
Cash
Cash
|
484000 | |
| CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
1515000 | |
| CY2020Q1 | us-gaap |
Inventory Net
InventoryNet
|
1100000 | |
| CY2019Q4 | us-gaap |
Inventory Net
InventoryNet
|
1246000 | |
| CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
207000 | |
| CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
3452000 | |
| CY2019Q4 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
358000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
668000 | |
| CY2019Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1335000 | |
| CY2019Q4 | us-gaap |
Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
|
367000 | |
| CY2019Q4 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
| CY2020Q1 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
2395000 | |
| CY2019Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-597000 | |
| CY2019Q1 | us-gaap |
Interest Expense
InterestExpense
|
14000 | |
| CY2019Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
583000 | |
| CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-906000 | |
| CY2019Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.12 | |
| CY2019Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7400000 | |
| CY2019Q1 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1489000 | |
| CY2020Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
517000 | |
| CY2020Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
303000 | |
| CY2019Q1 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
653000 | |
| CY2019Q1 | us-gaap |
Selling And Marketing Expense
SellingAndMarketingExpense
|
692000 | |
| CY2020Q1 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
-110000 | |
| CY2020Q1 | us-gaap |
Interest Expense
InterestExpense
|
28000 | |
| CY2020Q1 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
82000 | |
| CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-373000 | |
| CY2020Q1 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.05 | |
| CY2020Q1 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
7539000 | |
| CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
2537000 | |
| CY2020Q1 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
434000 | |
| CY2020Q1 | us-gaap |
Assets Current
AssetsCurrent
|
3380000 | |
| CY2020Q1 | us-gaap |
Inventory Noncurrent
InventoryNoncurrent
|
375000 | |
| CY2020Q1 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
630000 | |
| CY2020Q1 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
1351000 | |
| CY2020Q1 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
| CY2019Q1 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
13000 | |
| CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
418000 | |
| CY2019Q1 | isco |
Adjustments Related To Error Correction In Equity
AdjustmentsRelatedToErrorCorrectionInEquity
|
-4300000 | |
| CY2019Q1 | us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
1049000 | |
| CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
506000 | |
| CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-1114000 | |
| CY2020Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-373000 | |
| CY2019Q1 | us-gaap |
Profit Loss
ProfitLoss
|
-906000 | |
| CY2020Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
63000 | |
| CY2019Q1 | us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
72000 | |
| CY2020Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
71000 | |
| CY2019Q1 | us-gaap |
Operating Lease Expense
OperatingLeaseExpense
|
18000 | |
| CY2020Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
418000 | |
| CY2019Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
506000 | |
| CY2020Q1 | isco |
Inventory Adjustment
InventoryAdjustment
|
52000 | |
| CY2019Q1 | isco |
Inventory Adjustment
InventoryAdjustment
|
3000 | |
| CY2020Q1 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
25000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-377000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
306000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-77000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
-51000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
227000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-63000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-17000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
|
-4000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
-120000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
348000 | |
| CY2020Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
76000 | |
| CY2019Q1 | us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
390000 | |
| CY2020Q1 | isco |
Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
|
-81000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
265000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-341000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
3000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
58000 | |
| CY2020Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
38000 | |
| CY2019Q1 | us-gaap |
Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
|
61000 | |
| CY2020Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-41000 | |
| CY2019Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-119000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
224000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-460000 | |
| CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
484000 | |
| CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
1075000 | |
| CY2020Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
708000 | |
| CY2019Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
615000 | |
| CY2020Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2000 | |
| CY2019Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
2000 | |
| CY2020Q1 | us-gaap |
Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
|
421000 | |
| CY2020Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Reclassifications</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">For the three months ended March 31, 2020, the Company reclassified certain prior period amounts to conform to the current period presentation, as follows:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The carrying value and shares of the Company’s Series B, Series G, Series I-1 and Series I-2 non-redeemable convertible preferred stock were aggregated on the accompanying condensed consolidated balance sheets and statements of changes in redeemable convertible preferred stock and stockholders’ equity (deficit). Refer to Note 5 – Convertible Preferred Stock and Stockholders’ Equity (Deficit) for further information;</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non-cash operating lease expense was reclassified from changes in operating assets and liabilities to adjustments to reconcile net loss to net cash used in operating activities on the accompanying condensed consolidated statements of cash flows; and</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">•</p></td> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financed insurance premiums and payments on financed insurance premiums were reclassified from non-cash financing activities and cash flows from financing activities, respectively, to cash flows from operating activities on the accompanying condensed consolidated statements of cash flows;</p></td></tr></table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These reclassifications had no effect on previously reported net loss, stockholders’ equity (deficit) or cash flows for the prior period.</p> | |
| CY2020Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the accompanying condensed consolidated financial statements. Significant estimates include patent life (remaining legal life versus remaining useful life), inventory carrying values, allowance for excess and obsolete inventories, allowance for sales returns and doubtful accounts, and transactions using the Black-Scholes option valuation model, for example, common stock options and common stock warrants, as well as the Monte-Carlo simulation method for certain common stock warrants. Actual results could differ from those estimates.</p> | |
| CY2020Q1 | us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
<p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Customer Concentration</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three months ended March 31, 2020 and 2019, for the biomedical market segment, one customer accounted for approximately 49% and 42%, respectively, of consolidated revenues. No other single customer accounted for more than 10% of revenues for the periods ended.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;">Vendor Concentration </p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:3.33%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three months ended March 31, 2020<font style="color:#000000;">, two vendors accounted for approximately 14% and 11% of consolidated purchases, while during the same period in 2019 no single vendor accounted for more than 10% of consolidated purchases.</font></p> | |
| CY2020Q1 | us-gaap |
Number Of Reportable Segments
NumberOfReportableSegments
|
3 | |
| CY2020Q1 | isco |
Number Of Business Units
NumberOfBusinessUnits
|
2 | |
| CY2019Q4 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
207000 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value
FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
|
97000 | |
| CY2020Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
14920910 | |
| CY2019Q1 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
15562515 | |
| CY2019Q4 | us-gaap |
Inventory Raw Materials
InventoryRawMaterials
|
688000 | |
| CY2019Q4 | us-gaap |
Inventory Work In Process
InventoryWorkInProcess
|
492000 | |
| CY2019Q4 | us-gaap |
Inventory Finished Goods
InventoryFinishedGoods
|
1219000 | |
| CY2019Q4 | us-gaap |
Inventory Gross
InventoryGross
|
2399000 | |
| CY2019Q4 | us-gaap |
Inventory Valuation Reserves
InventoryValuationReserves
|
795000 | |
| CY2020Q1 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
| CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
|
12000 | |
| CY2019Q4 | isco |
Inventory Net Current And Noncurrent
InventoryNetCurrentAndNoncurrent
|
1604000 | |
| CY2020Q1 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3413000 | |
| CY2019Q4 | us-gaap |
Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
|
3410000 | |
| CY2019Q1 | us-gaap |
Depreciation
Depreciation
|
37000 | |
| CY2020Q1 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2783000 | |
| CY2020Q1 | us-gaap |
Fair Value Assets Level1 To Level2 Transfers Amount
FairValueAssetsLevel1ToLevel2TransfersAmount
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Assets Level2 To Level1 Transfers Amount
FairValueAssetsLevel2ToLevel1TransfersAmount
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Liabilities Level1 To Level2 Transfers Amount
FairValueLiabilitiesLevel1ToLevel2TransfersAmount
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Liabilities Level2 To Level1 Transfers Amount
FairValueLiabilitiesLevel2ToLevel1TransfersAmount
|
0 | |
| CY2019Q4 | us-gaap |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
2742000 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3
|
0 | |
| CY2020Q1 | us-gaap |
Fair Value Measurement With Unobservable Inputs Reconciliation Liability Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3
|
0 | |
| CY2020Q1 | us-gaap |
Depreciation
Depreciation
|
41000 | |
| CY2008Q2 | isco |
Advances From Nonaffiliated Collaboration
AdvancesFromNonaffiliatedCollaboration
|
250000 | |
| CY2008Q2 | isco |
Specified Amount Of Revenue To Be Utilized First For Advances
SpecifiedAmountOfRevenueToBeUtilizedFirstForAdvances
|
250000 | |
| CY2020Q1 | us-gaap |
Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
|
0 | |
| CY2020Q1 | us-gaap |
Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
|
P15Y | |
| CY2020Q1 | us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
2 | |
| CY2020Q1 | us-gaap |
Revenue Performance Obligation Description Of Payment Terms
RevenuePerformanceObligationDescriptionOfPaymentTerms
|
The Company's revenue consists primarily of sales of products from its two revenue-generating operating segments, the biomedical products market and anti-aging cosmetic products market business segments. The biomedical market segment markets and sells primary human cell research products with two product categories, cells and media, which are sold both domestically within the United States and internationally. The anti-aging cosmetic market segment markets and sells a line of luxury skincare products sold through two sales channels: ecommerce and professional. The ecommerce channel sells direct to customers through online orders, while professional sales are to spas, salons and other skincare providers. | |
| CY2020Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | |
| CY2019Q1 | us-gaap |
Asset Impairment Charges
AssetImpairmentCharges
|
0 | |
| CY2020Q1 | isco |
Product Return Guarantee Period
ProductReturnGuaranteePeriod
|
P30D | |
| CY2020Q1 | isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | |
| CY2019 | isco |
Allowance For Sales Return
AllowanceForSalesReturn
|
0 | |
| CY2020Q1 | isco |
Financial Assets Fair Value Disclosure
FinancialAssetsFairValueDisclosure
|
0 | |
| CY2020Q1 | us-gaap |
Financial Liabilities Fair Value Disclosure
FinancialLiabilitiesFairValueDisclosure
|
0 | |
| CY2020Q1 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2306000 | |
| CY2019Q4 | us-gaap |
Finite Lived Patents Gross
FiniteLivedPatentsGross
|
2268000 | |
| CY2020Q1 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1030000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
1008000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
1260000 | |
| CY2020Q1 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
| CY2019Q1 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
35000 | |
| CY2019Q4 | isco |
Indefinite Life Logos And Trademarks
IndefiniteLifeLogosAndTrademarks
|
75000 | |
| CY2020Q1 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1351000 | |
| CY2019Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
1335000 | |
| CY2019Q1 | us-gaap |
Debt Instrument Face Amount
DebtInstrumentFaceAmount
|
1000000 | |
| CY2019Q1 | us-gaap |
Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
|
49000 | |
| CY2020Q1 | isco |
Convertible Common Stock Conversion Price
ConvertibleCommonStockConversionPrice
|
1.75 | |
| CY2014Q4 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
62047 | |
| CY2016Q1 | isco |
Class Of Warrant Or Right Issued Exercisable For Shares Of Common Stock
ClassOfWarrantOrRightIssuedExercisableForSharesOfCommonStock
|
11159995 | |
| CY2014Q4 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
| CY2016Q1 | us-gaap |
Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
|
1.75 | |
| CY2020Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
418000 | |
| CY2019Q1 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
506000 | |
| CY2020Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
|
1400000 | |
| CY2020Q1 | us-gaap |
Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
|
P1Y4M20D | |
| CY2020Q1 | us-gaap |
Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
|
19620605 | |
| CY2020Q1 | isco |
Related Party Rent Expense
RelatedPartyRentExpense
|
41000 | |
| CY2019Q1 | isco |
Related Party Rent Expense
RelatedPartyRentExpense
|
40000 | |
| CY2019Q2 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
1000000 | |
| CY2019Q2 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
800000 | |
| CY2019Q4 | us-gaap |
Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
|
500000 | |
| CY2019Q4 | us-gaap |
Due To Related Parties Current
DueToRelatedPartiesCurrent
|
500000 | |
| CY2020Q1 | isco |
Number Of Operating Leases
NumberOfOperatingLeases
|
3 | |
| CY2020Q1 | us-gaap |
Operating Lease Liability
OperatingLeaseLiability
|
1400000 |
